BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34343386)

  • 1. A molecular approach to maggot debridement therapy with Lucilia sericata and its excretions/secretions in wound healing.
    Tombulturk FK; Kanigur-Sultuybek G
    Wound Repair Regen; 2021 Nov; 29(6):1051-1061. PubMed ID: 34343386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and partial characterization of antifungal bioactivity from the secretions of the medicinal maggot, Lucilia sericata.
    Evans R; Dudley E; Nigam Y
    Wound Repair Regen; 2015; 23(3):361-8. PubMed ID: 25847128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis.
    Bexfield A; Bond AE; Morgan C; Wagstaff J; Newton RP; Ratcliffe NA; Dudley E; Nigam Y
    Br J Dermatol; 2010 Mar; 162(3):554-62. PubMed ID: 19799603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Maggot Debridement Therapy on Refractory Atypical Diabetic Foot Ulcers: An Open-Label Study.
    Siavash M; Najjarnezhad A; Mohseni N; Abtahi SM; Karimy A; Sabzevari MH
    Int J Low Extrem Wounds; 2021 Dec; 20(4):315-320. PubMed ID: 32370633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maggot debridement therapy for an electrical burn injury with instructions for the use of Lucilia sericata larvae.
    Nasoori A; Hoomand R
    J Wound Care; 2017 Dec; 26(12):734-741. PubMed ID: 29244970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications for maggots in wound care.
    Mumcuoglu KY
    Am J Clin Dermatol; 2001; 2(4):219-27. PubMed ID: 11705249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Chronic Wound Debridement with the Use of Larvae of
    Bazaliński D; Kózka M; Karnas M; Więch P
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31684038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Lucilia sericata on wound healing in streptozotocin-induced diabetic rats and analysis of its secretome at the proteome level.
    Tombulturk FK; Kasap M; Tuncdemir M; Polat E; Sirekbasan S; Kanli A; Kanigur-Sultuybek G
    Hum Exp Toxicol; 2018 May; 37(5):508-520. PubMed ID: 28621210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maggot therapy in wound management].
    Falch BM; de Weerd L; Sundsfjord A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
    Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
    Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Report on the Use of Larvae of Cochliomyia macellaria (Diptera: Calliphoridae) for Wound Treatment in Veterinary Practice.
    Masiero FS; Aguiar ESV; Pereira DIB; Thyssen PJ
    J Med Entomol; 2020 May; 57(3):965-968. PubMed ID: 31819964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.
    Telford G; Brown AP; Rich A; English JS; Pritchard DI
    Med Vet Entomol; 2012 Sep; 26(3):291-9. PubMed ID: 22620282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midgut lysozymes of Lucilia sericata - new antimicrobials involved in maggot debridement therapy.
    Valachova I; Takac P; Majtan J
    Insect Mol Biol; 2014 Dec; 23(6):779-87. PubMed ID: 25098233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens.
    Bohova J; Majtan J; Majtan V; Takac P
    Evid Based Complement Alternat Med; 2014; 2014():857360. PubMed ID: 25013449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretions/secretions from medicinal larvae (Lucilia sericata) inhibit complement activation by two mechanisms.
    Tamura T; Cazander G; Rooijakkers SH; Trouw LA; Nibbering PH
    Wound Repair Regen; 2017 Jan; 25(1):41-50. PubMed ID: 28019718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biosurgical débridement using Lucilia sericata-maggots - an update].
    Nenoff P; Herrmann A; Gerlach C; Herrmann J; Simon JC
    Wien Med Wochenschr; 2010 Dec; 160(21-22):578-85. PubMed ID: 20714816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does maggot therapy promote wound healing? The clinical and cellular evidence.
    Nigam Y; Morgan C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):776-82. PubMed ID: 26691053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots.
    Franta Z; Vogel H; Lehmann R; Rupp O; Goesmann A; Vilcinskas A
    Biomed Res Int; 2016; 2016():8285428. PubMed ID: 27119084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.